Subjects and methods: Progressive and retrospective descriptive research on 73 patients with rectal cancer Stage III from December 2015 to March 2019 who have received preoperative chemoradiotherapy with 50.4Gy / Fx dose in 5.5 weeks with Capecitabine 825mg / m2, twice a day x 5 - 7 days / week and surgery.